Immatics (IMTX) Shares Outstanding (2020 - 2025)
Immatics' (IMTX) quarterly Shares Outstanding came in at $156.1 million in Q4 2025, up 20.15% year-on-year from $129.9 million in Q4 2024, and up 20.15% quarter-over-quarter from $129.9 million in Q4 2024.
Immatics (IMTX) Shares Outstanding (2020 - 2025) Analysis & Trends
Immatics has disclosed Shares Outstanding across 6 years of filings, most recently posting $156.1 million for Q4 2025.
- Shares Outstanding for Q4 2025 came in at $156.1 million, up 20.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $156.1 million (up 20.15% YoY), and the FY2025 annual result was $151.5 million, up 16.62% from the prior year.
- Shares Outstanding came in at $156.1 million for Q4 2025 at Immatics, up from $129.9 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $156.1 million in Q4 2025 to a low of $72.0 million in Q4 2021.
- The 5-year median for Shares Outstanding is $91.1 million (2023), against an average of $105.4 million.
- Across the five-year window, Shares Outstanding fell 4.02% in 2021 and soared 42.6% in 2024, its largest moves.
- Immatics' Shares Outstanding stood at $72.0 million in 2021, then grew by 8.66% to $78.2 million in 2022, then climbed by 16.44% to $91.1 million in 2023, then jumped by 42.6% to $129.9 million in 2024, then grew by 20.15% to $156.1 million in 2025.
- The last three Shares Outstanding figures came in at $156.1 million (Q4 2025), $129.9 million (Q4 2024), and $91.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 156.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2025 | 156.06 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2024 | 129.89 Mn |
| Dec 31, 2023 | 91.09 Mn |
| Dec 31, 2023 | 91.09 Mn |
| Dec 31, 2023 | 91.09 Mn |
| Dec 31, 2023 | 91.09 Mn |